The Blood and Marrow Transplantation & Cellular Therapy (BMT-CT) program at Stanford performs autologous and allogeneic transplantations for over 300 patients each year. The program has been very successful with a history of limited morbidity rates and acute mortality that is well below most published reports. In addition to a successful clinical practice, our program researchers are translating their discoveries into new therapies, advancing the efficacy of hematopoietic cell transplantation for patients worldwide.BMT-CT is seeking a Clinical Trials Regulatory II Specialist to support a very active clinical trials faculty. The po